Expert Panel to C.D.C. to Vote on Johnson & Johnson Vaccine Pause
An advisory committee for the Centers for Disease Control and Prevention will meet on Wednesday afternoon to discuss whether the Johnson & Johnson Covid-19 vaccine should remain paused while a possible link to rare blood clots is investigated. The emergency meeting follows the Food and Drug Administration’s announcement on Tuesday that it was studying six…